Reye's syndrome: An Overview

Author(s)	Ms. Shilpa J
Country	India
Abstract	Reye’s syndrome, a rare but severe illness, was first identified in 1963 by Australian pathologist Douglas Reye. This potentially fatal condition primarily affects children, typically those between the ages of 4 and 12, during or after recovery from viral infections such as chickenpox, influenza, mumps, or measles. It involves the acute onset of brain swelling (encephalopathy) and liver failure. The syndrome is strongly associated with the use of aspirin or aspirin-like products during viral illness. While the exact cause remains unknown, the condition can lead to significant morbidity and a high mortality rate, ranging from 20% to 40%. Early identification of symptoms and prompt treatment can help reduce risks. The management is supportive and involves collaboration with pediatricians, neurologists, and hepatologists.
Keywords	Reye’s syndrome, encephalopathy, liver failure, aspirin, viral infection, pediatric care, supportive therapy.
Field	Medical / Pharmacy
Published In	Volume 7, Issue 2, March-April 2025
Published On	2025-03-28
DOI	https://doi.org/10.36948/ijfmr.2025.v07i02.39997
Short DOI	https://doi.org/g898gv

About IJFMR Fees & Payment Current Issue Publication Archive	Submit Research Paper Track Submission Status Publication Guidelines Publication Ethics Peer Review & Plagiarism	Join as a Reviewer Editors & Reviewers Reviewer Referral Program Get Reviewer Membership Certi.	Website/Journal Policies Usage Policy Content Policies Privacy Policy

Contact Us		+91-9687-828-838	editor@ijfmr.com

International Journal For Multidisciplinary Research